[HTML][HTML] Generation of cardio-protective antibodies after pneumococcal polysaccharide vaccine: Early results from a randomised controlled trial
S Ren, PM Hansbro, W Srikusalanukul, JC Horvat… - Atherosclerosis, 2022 - Elsevier
Background and aims Observational studies have demonstrated that the pneumococcal
polysaccharide vaccine (PPV) is associated with reduced risk of cardiovascular events. This …
polysaccharide vaccine (PPV) is associated with reduced risk of cardiovascular events. This …
Rationale and design of a randomized controlled trial of pneumococcal polysaccharide vaccine for prevention of cardiovascular events: the Australian Study for the …
Background Research has shown that vaccination with Streptococcus pneumoniae reduced
the extent of atherosclerosis in experimental animal models. It is thought that …
the extent of atherosclerosis in experimental animal models. It is thought that …
Effect of the adult pneumococcal polysaccharide vaccine on cardiovascular disease: a systematic review and meta-analysis
Animal models and clinical studies suggest a mechanistic link between the pneumococcal
polysaccharide vaccine (PPV) and a cardiovascular protective effect. However, conflicting …
polysaccharide vaccine (PPV) and a cardiovascular protective effect. However, conflicting …
[HTML][HTML] The protective effect of pneumococcal vaccination on cardiovascular disease in adults: A systematic review and meta-analysis
F Marra, A Zhang, E Gillman, K Bessai, K Parhar… - International Journal of …, 2020 - Elsevier
Background Epidemiological studies suggest that there is a link between pneumococcal
infection and adverse cardiovascular outcomes such as myocardial infarction. Multiple …
infection and adverse cardiovascular outcomes such as myocardial infarction. Multiple …
Effect of pneumococcal vaccine on mortality and cardiovascular outcomes: a systematic review and meta-analysis
Various studies have suggested the possible cardiovascular (CV) protective effects of the
pneumococcal vaccine (PV). Therefore, we conducted a meta-analysis to assess the …
pneumococcal vaccine (PV). Therefore, we conducted a meta-analysis to assess the …
Evaluating the clinical effectiveness of pneumococcal vaccination in preventing myocardial infarction: The CAPAMIS study, three-year follow-up
O Ochoa-Gondar, A Vila-Corcoles, T Rodriguez-Blanco… - Vaccine, 2014 - Elsevier
Background Cardiovascular benefits using the 23-valent pneumococcal polysaccharide
vaccine (PPV23) are controversial. This study assessed clinical effectiveness of PPV23 in …
vaccine (PPV23) are controversial. This study assessed clinical effectiveness of PPV23 in …
Association between pneumococcal vaccination and cardiovascular outcomes: a systematic review and meta-analysis of cohort studies
CV Vlachopoulos, DG Terentes-Printzios… - European journal of …, 2015 - academic.oup.com
Aims Streptococcus pneumoniae is the most common cause of community-acquired
pneumonia (CAP) and CAP-related mortality in adults. Pneumococcal vaccination (PV) …
pneumonia (CAP) and CAP-related mortality in adults. Pneumococcal vaccination (PV) …
Pneumococcal vaccination in adults at very high risk or with established cardiovascular disease: systematic review and meta-analysis
Aims There are several guidelines that recommend pneumococcal vaccination (PPSV23
and/or PCV13) in adults with a history of cardiovascular disease (established heart failure …
and/or PCV13) in adults with a history of cardiovascular disease (established heart failure …
Pneumococcal vaccination may induce anti-oxidized low-density lipoprotein antibodies that have potentially protective effects against cardiovascular disease
Many animal and human studies have found an inverse association between anti-oxidized
low-density lipoprotein (oxLDL) antibodies (anti-oxLDL) and atherosclerotic burden …
low-density lipoprotein (oxLDL) antibodies (anti-oxLDL) and atherosclerotic burden …
Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up
A Vila-Corcoles, O Ochoa-Gondar… - BMC Public Health, 2012 - Springer
Background Conflicting results have been recently reported evaluating the relationship
between pneumococcal vaccination and the risk of thrombotic vascular events. This study …
between pneumococcal vaccination and the risk of thrombotic vascular events. This study …